{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670318415035776.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/art.24283"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.24283"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.24283"}},{"identifier":{"@type":"PMID","@value":"19248121"}}],"dc:title":[{"@value":"<i>Pneumocystis jiroveci</i>\n                    pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patients"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title>\n                  <jats:sec>\n                    <jats:title>Objective</jats:title>\n                    <jats:p>\n                      To establish proper management of\n                      <jats:italic>Pneumocystis jiroveci</jats:italic>\n                      pneumonia (PCP) in rheumatoid arthritis (RA) patients treated with infliximab. PCP has been observed in 0.4% of patients with RA treated with infliximab in Japan.\n                    </jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods</jats:title>\n                    <jats:p>Data from patients with RA (n = 21) who were diagnosed with PCP during infliximab treatment and from 102 patients with RA who did not develop PCP during infliximab therapy were collected from 14 rheumatology referral centers in Japan. A retrospective review of these patients and a case–control study to compare patients with and without PCP were performed.</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Results</jats:title>\n                    <jats:p>\n                      The median length of time from the first infliximab infusion to the development of PCP was 8.5 weeks. At the onset of PCP, the median dosages of prednisolone and methotrexate were 7.5 mg/day and 8 mg/week, respectively.\n                      <jats:italic>Pneumocystis jiroveci</jats:italic>\n                      was microscopically identified in only 2 patients, although the polymerase chain reaction test for the organism was positive in 20 patients. The patients with PCP had significantly lower serum albumin levels (\n                      <jats:italic>P</jats:italic>\n                      < 0.001) and lower serum IgG levels (\n                      <jats:italic>P</jats:italic>\n                      < 0.001) than the patients without PCP. Computed tomography of the chest in all patients with PCP revealed ground‐glass opacity either with sharp demarcation by interlobular septa or without interlobular septal boundaries. Sixteen of the 21 patients with PCP developed acute respiratory failure, but all survived.\n                    </jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion</jats:title>\n                    <jats:p>PCP is a serious complication that may occur early in the course of infliximab therapy in patients with RA. For the proper clinical management of this infectious disease, physicians need to be aware of the possibility of PCP developing during infliximab therapy.</jats:p>\n                  </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670318415035782","@type":"Researcher","foaf:name":[{"@value":"Yukiko Komano"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035653","@type":"Researcher","foaf:name":[{"@value":"Masayoshi Harigai"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035654","@type":"Researcher","foaf:name":[{"@value":"Ryuji Koike"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035780","@type":"Researcher","foaf:name":[{"@value":"Haruhito Sugiyama"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035659","@type":"Researcher","foaf:name":[{"@value":"Jun Ogawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035648","@type":"Researcher","foaf:name":[{"@value":"Kazuyoshi Saito"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035784","@type":"Researcher","foaf:name":[{"@value":"Naoya Sekiguchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035652","@type":"Researcher","foaf:name":[{"@value":"Masayuki Inoo"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035662","@type":"Researcher","foaf:name":[{"@value":"Ikuko Onishi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035661","@type":"Researcher","foaf:name":[{"@value":"Hiroyuki Ohashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035783","@type":"Researcher","foaf:name":[{"@value":"Fujio Amamoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035657","@type":"Researcher","foaf:name":[{"@value":"Masayuki Miyata"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035660","@type":"Researcher","foaf:name":[{"@value":"Hideo Ohtsubo"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035779","@type":"Researcher","foaf:name":[{"@value":"Kazuko Hiramatsu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035651","@type":"Researcher","foaf:name":[{"@value":"Masahiro Iwamoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035658","@type":"Researcher","foaf:name":[{"@value":"Seiji Minota"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035649","@type":"Researcher","foaf:name":[{"@value":"Naoki Matsuoka"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035778","@type":"Researcher","foaf:name":[{"@value":"Goichi Kageyama"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035777","@type":"Researcher","foaf:name":[{"@value":"Kazuyoshi Imaizumi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035663","@type":"Researcher","foaf:name":[{"@value":"Hitoshi Tokuda"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035781","@type":"Researcher","foaf:name":[{"@value":"Yasumi Okochi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035776","@type":"Researcher","foaf:name":[{"@value":"Koichiro Kudo"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035655","@type":"Researcher","foaf:name":[{"@value":"Yoshiya Tanaka"}]},{"@id":"https://cir.nii.ac.jp/crid/1030003658330673152","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50179610"},{"@type":"NRID","@value":"1000050179610"},{"@type":"NRID","@value":"9000000877887"},{"@type":"NRID","@value":"9000014207889"},{"@type":"NRID","@value":"9000016383446"},{"@type":"NRID","@value":"9000001489795"},{"@type":"NRID","@value":"9000322108971"},{"@type":"NRID","@value":"9000021351486"},{"@type":"NRID","@value":"9000375886183"},{"@type":"NRID","@value":"9000398138928"},{"@type":"NRID","@value":"9000255799752"},{"@type":"NRID","@value":"9000001333374"},{"@type":"NRID","@value":"9000379605985"},{"@type":"NRID","@value":"9000007404496"},{"@type":"NRID","@value":"9000340953057"},{"@type":"NRID","@value":"9000391771181"},{"@type":"NRID","@value":"9000257926109"},{"@type":"NRID","@value":"9000307251157"},{"@type":"NRID","@value":"9000259336870"},{"@type":"NRID","@value":"9000413476545"},{"@type":"NRID","@value":"9000340953021"},{"@type":"NRID","@value":"9000254617642"},{"@type":"NRID","@value":"9000017036355"},{"@type":"NRID","@value":"9000323291007"},{"@type":"NRID","@value":"9000021357712"},{"@type":"NRID","@value":"9000375922338"},{"@type":"NRID","@value":"9000325829809"},{"@type":"NRID","@value":"9000290133212"},{"@type":"NRID","@value":"9000240536408"},{"@type":"NRID","@value":"9000412228840"},{"@type":"NRID","@value":"9000298898221"},{"@type":"NRID","@value":"9000258517290"},{"@type":"NRID","@value":"9000257925989"},{"@type":"NRID","@value":"9000009536874"},{"@type":"NRID","@value":"9000000669795"},{"@type":"NRID","@value":"9000015160947"},{"@type":"NRID","@value":"9000259336893"},{"@type":"NRID","@value":"9000014602062"},{"@type":"NRID","@value":"9000022105317"},{"@type":"NRID","@value":"9000408630841"},{"@type":"NRID","@value":"9000391777352"},{"@type":"NRID","@value":"9000000381633"},{"@type":"NRID","@value":"9000340953187"},{"@type":"NRID","@value":"9000340953079"},{"@type":"NRID","@value":"9000340953032"},{"@type":"NRID","@value":"9000022122608"},{"@type":"NRID","@value":"9000391775593"},{"@type":"NRID","@value":"9000391777113"},{"@type":"NRID","@value":"9000254450715"},{"@type":"NRID","@value":"9000253373883"},{"@type":"NRID","@value":"9000000736177"},{"@type":"NRID","@value":"9000001758253"},{"@type":"NRID","@value":"9000340953159"},{"@type":"NRID","@value":"9000021888840"},{"@type":"NRID","@value":"9000391771365"},{"@type":"NRID","@value":"9000345290454"},{"@type":"NRID","@value":"9000255680826"},{"@type":"NRID","@value":"9000283415068"},{"@type":"NRID","@value":"9000256607339"},{"@type":"NRID","@value":"9000314791566"},{"@type":"NRID","@value":"9000329896112"},{"@type":"NRID","@value":"9000340953044"},{"@type":"NRID","@value":"9000018782441"},{"@type":"NRID","@value":"9000340953195"},{"@type":"NRID","@value":"9000340953203"},{"@type":"NRID","@value":"9000021930965"},{"@type":"NRID","@value":"9000365496796"},{"@type":"NRID","@value":"9000391775790"},{"@type":"NRID","@value":"9000283722975"},{"@type":"NRID","@value":"9000315680782"},{"@type":"NRID","@value":"9000265248375"},{"@type":"NRID","@value":"9000020422888"},{"@type":"NRID","@value":"9000392783610"},{"@type":"NRID","@value":"9000107381121"},{"@type":"NRID","@value":"9000002531327"},{"@type":"NRID","@value":"9000257970651"},{"@type":"NRID","@value":"9000413480342"},{"@type":"NRID","@value":"9000380481812"},{"@type":"NRID","@value":"9000262367176"},{"@type":"NRID","@value":"9000259337073"},{"@type":"NRID","@value":"9000265566113"},{"@type":"NRID","@value":"9000368418366"},{"@type":"NRID","@value":"9000261023324"},{"@type":"NRID","@value":"9000017645746"},{"@type":"NRID","@value":"9000242161435"},{"@type":"NRID","@value":"9000326644699"},{"@type":"NRID","@value":"9000240536366"},{"@type":"NRID","@value":"9000340952994"},{"@type":"NRID","@value":"9000398139320"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0023699"}],"foaf:name":[{"@value":"Tsutomu Takeuchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318415035656","@type":"Researcher","foaf:name":[{"@value":"Nobuyuki Miyasaka"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"08937524"},{"@type":"EISSN","@value":"15290123"}],"prism:publicationName":[{"@value":"Arthritis Care & Research"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2009-02-26","prism:volume":"61","prism:number":"3","prism:startingPage":"305","prism:endingPage":"312"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.24283"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.24283"}],"createdAt":"2009-02-26","modifiedAt":"2023-11-13","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Tumor%20Necrosis%20Factor-alpha","dc:title":"Tumor Necrosis Factor-alpha"},{"@id":"https://cir.nii.ac.jp/all?q=Pneumonia,%20Pneumocystis","dc:title":"Pneumonia, Pneumocystis"},{"@id":"https://cir.nii.ac.jp/all?q=Antibodies,%20Monoclonal","dc:title":"Antibodies, Monoclonal"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Pneumocystis%20carinii","dc:title":"Pneumocystis carinii"},{"@id":"https://cir.nii.ac.jp/all?q=Infliximab","dc:title":"Infliximab"},{"@id":"https://cir.nii.ac.jp/all?q=Arthritis,%20Rheumatoid","dc:title":"Arthritis, Rheumatoid"},{"@id":"https://cir.nii.ac.jp/all?q=Anti-Infective%20Agents","dc:title":"Anti-Infective Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Risk%20Factors","dc:title":"Risk Factors"},{"@id":"https://cir.nii.ac.jp/all?q=Antirheumatic%20Agents","dc:title":"Antirheumatic Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Trimethoprim,%20Sulfamethoxazole%20Drug%20Combination","dc:title":"Trimethoprim, Sulfamethoxazole Drug Combination"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Retrospective%20Studies","dc:title":"Retrospective Studies"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001202663101056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Incidence and Risk Factors for Infections Requiring Hospitalization Including Pneumocystis Pneumonia in Japanese Patients with Rheumatoid Arthritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002217661283712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232283537408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389817770240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690325642624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707093770240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of cimetidine on pentamidine induced hyperglycemia in rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360295892010047488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical characteristics and risk factors for<i>Pneumocystis jirovecii</i>pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189656541696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664146803968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible preventive effect of salazosulfapyridine against development of <i><b>Pneumocystis</b></i> pneumonia in methotrexate-receiving patients with rheumatoid arthritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204870545152","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of <i>Pneumocystis</i> Pneumonia in Japan Revealed by a Multicenter Study"},{"@value":"Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: Importance of Pneumocystis pneumonia in Japan revealed by a multicenter study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205322095232","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"サルコイドーシスへのTNF阻害薬の使用"},{"@language":"en","@value":"Tumor Necrosis Factor Inhibitors for the Therapy of Refractory Sarcoidosis"},{"@value":"サルコイドーシスへのTNF阻害薬の使用 : 有害事象とそのsafety management"},{"@language":"ja-Kana","@value":"サルコイドーシス エ ノ TNF ソガイヤク ノ シヨウ : ユウガイ ジショウ ト ソノ safety management"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205396532352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pneumocystis Infections"},{"@language":"ja","@value":"Pneumocystis Infections"},{"@value":"教育シリーズ : Deep-seated mycosis Pneumocystis Infections"},{"@language":"ja-Kana","@value":"キョウイク シリーズ : Deep-seated mycosis Pneumocystis Infections"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206240053120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with <i>Pneumocystis jirovecii</i>"},{"@value":"Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206432981888","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Pneumocystis Pneumonia (PCP) That Developed during Infliximab (IFX) Therapy"},{"@language":"ja","@value":"インフリキシマブ投与中に発症したニューモシスチス肺炎の一例"},{"@value":"症例報告 インフリキシマブ投与中に発症したニューモシスチス肺炎の一例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク インフリキシマブ トウヨ チュウ ニ ハッショウ シタ ニューモシスチス ハイエン ノ イチレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390009224750567296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679630667776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab"},{"@language":"ja","@value":"アダリムマブ投与中にニューモシスチス肺炎を発症した関節リウマチ患者２例の報告"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680234958464","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment trends of rheumatoid arthritis in Japan: Changes toward globalization and its unique innovation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681420097024","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Infectious Disease and Opportunistic Infection"},{"@language":"ja","@value":"1．感染症と日和見感染"},{"@value":"感染症と日和見感染"},{"@language":"ja-Kana","@value":"カンセンショウ ト ヒヨリミ カンセン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681422498432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"8. Risk and Management of Infectious Complications in Patients with Autoimmune Diseases Treated with Biologicals"},{"@language":"ja","@value":"8．生物学的製剤使用患者の感染症リスクと対策"},{"@value":"教育講演 生物学的製剤使用患者の感染症リスクと対策"},{"@language":"ja-Kana","@value":"キョウイク コウエン セイブツガクテキ セイザイ シヨウ カンジャ ノ カンセンショウ リスク ト タイサク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681423006592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Opportunistic Infections"},{"@language":"ja","@value":"3．注意すべき日和見感染症"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573571407251200","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Retrospective Study of the Frequency of TMP/SMX Prophylaxis Use and the Incidence of Pneumocystis Pneumonia Following Systemic Corticosteroid Therapy in Intraocular Inflammatory Disease Patients"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/art.24283"},{"@type":"OPENAIRE","@value":"doi_dedup___::19e5d7f395e1657b3242edc7cf078493"},{"@type":"CROSSREF","@value":"10.1093/rheumatology/keu395_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2492/inflammregen.31.25_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2177/jsci.34.420_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.4264/numa.69.58_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.50.4508_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.3390/ijms24087399_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1007/s10165-012-0657-2_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1186/s13075-016-1206-8_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2169/naika.102.2404_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2169/naika.102.2631_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1155/2017/6730812_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.3899/jrheum.140778_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.2169/naika.98.2453_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.47.272_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1007/s10165-012-0796-5_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.3109/14397595.2015.1118196_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2012.07.043_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.3314/mmj.53.13_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.7878/jjsogd.34.19_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.1016/j.jiac.2018.11.014_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"},{"@type":"CROSSREF","@value":"10.7883/yoken.jjid.2014.546_references_DOI_GzfUy1iimc5tHGFhgSxsAb0A65P"}]}